Parkinson Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients conform to the diagnostic criteria of PD; 2. Aged between 40 and 75 years old; 3. conform to the classification criteria of PD: The stage of revised Hoehn-Yahr Scale between I-III levels; 4. inpatients or outpatients of follow-up; 5. The initial patient, without any treatment of the Parkinson Disease; 6. receive the treatments voluntarily and sign informed consent form.;Inclusion criteria: 1. Patients conform to the diagnostic criteria of PD; 2. Aged between 40 and 75 years old; 3. conform to the classification criteria of PD: The stage of revised Hoehn-Yahr Scale between I-III levels; 4. inpatients or outpatients of follow-up; 5. The initial patient, without any treatment of the Parkinson Disease; 6. receive the treatments voluntarily and sign informed consent form.;Inclusion criteria: 1. Patients conform to the diagnostic criteria of PD; 2. Aged between 40 and 75 years old; 3. conform to the classification criteria of PD: The stage of revised Hoehn-Yahr Scale between I-III levels; 4. inpatients or outpatients of follow-up; 5. The initial patient, without any treatment of the Parkinson Disease; 6. receive the treatments voluntarily and sign informed consent form.;Inclusion criteria: 1. Patients conform to the diagnostic criteria of PD; 2. Aged between 40 and 75 years old; 3. conform to the classification criteria of PD: The stage of revised Hoehn-Yahr Scale between I-III levels; 4. inpatients or outpatients of follow-up; 5. The initial patient, without any treatment of the Parkinson Disease; 6. receive the treatments voluntarily and sign informed consent form.;Inclusion criteria: 1. Patients conform to the diagnostic criteria of PD; 2. Aged between 40 and 75 years old; 3. conform to the classification criteria of PD: The stage of revised Hoehn-Yahr Scale between I-III levels; 4. inpatients or outpatients of follow-up; 5. The initial patient, without any treatment of the Parkinson Disease; 6. receive the treatments voluntarily and sign informed consent form.
Exclusion criteria
Exclusion criteria: 1. secondary Parkinson's disease; 2. Participants with severe primary disease of the cardiovascular, hepatic, renal, or hematopoietic system; 3. patients with a simultaneous psychiatric or other severe disease; 4. Participants who are allergic to the Madopar or Acupuncture.;Exclusion criteria: 1. secondary Parkinson's disease; 2. Participants with severe primary disease of the cardiovascular, hepatic, renal, or hematopoietic system; 3. patients with a simultaneous psychiatric or other severe disease; 4. Participants who are allergic to the Madopar or Acupuncture.;Exclusion criteria: 1. secondary Parkinson's disease; 2. Participants with severe primary disease of the cardiovascular, hepatic, renal, or hematopoietic system; 3. patients with a simultaneous psychiatric or other severe disease; 4. Participants who are allergic to the Madopar or Acupuncture.;Exclusion criteria: 1. secondary Parkinson's disease; 2. Participants with severe primary disease of the cardiovascular, hepatic, renal, or hematopoietic system; 3. patients with a simultaneous psychiatric or other severe disease; 4. Participants who are allergic to the Madopar or Acupuncture.;Exclusion criteria: 1. secondary Parkinson's disease; 2. Participants with severe primary disease of the cardiovascular, hepatic, renal, or hematopoietic system; 3. patients with a simultaneous psychiatric or other severe disease; 4. Participants who are allergic to the Madopar or Acupuncture.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UPDRS;Modified Webster;Berg balance scale;PDQ-39;Beck Anxiety Inventory;Beck Depression Inventory;TESS; | — |
Secondary
| Measure | Time frame |
|---|---|
| HAMD;HAMA;SDS;PDSS; | — |
Countries
China
Contacts
College of TCM, Southern Medical University;College of TCM, Southern Medical University;College of TCM, Southern Medical University;College of TCM, Southern Medical University;College of TCM, Southern Medical University